Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
APC Mouse anti-Human Ig, κ Light Chain
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
Polyclonal versus monoclonal immunoglobulin-free light chains quantification - Giuseppe Di Noto, Elena Cimpoies, Alessandra Dossi, Lucia Paolini, Annalisa Radeghieri, Luigi Caimi, Doris Ricotta, 2015
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Immunoglobulin Light Chain - an overview | ScienceDirect Topics
Sebia FLC Kappa, Serum free light chain quantification
![Anti-Kappa light chain antibody [MEM-09] (ab1050) | Abcam](https://www.abcam.com/ps/products/1/ab1050/Images/ab1050-521319-anti-kappa-light-chain-antibody-mem-09-flow-cytometry-peripheral-blood-human.jpg "Anti-Kappa light chain antibody [MEM-09] (ab1050) | Abcam")
Anti-Kappa light chain antibody [MEM-09] (ab1050) | Abcam
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
![PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam](https://www.abcam.com/ps/products/131/ab131602/Images/ab131602-273625-anti-kappa-light-chain-antibody-tb28-2-prediluted-phycoerythrin-flow-cytometry.jpg "PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam")
PE Anti-Kappa light chain antibody [TB28-2] (ab131602) | Abcam
Guide to Antibody structure and isotypes | Abcam
